KLA Corporation R&D increased by 1.3% to $388.76M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.0%, from $338.04M to $388.76M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 10.0% CAGR.
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
research_and_development| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $241.43M | $258.15M | $265.03M | $285.19M | $296.88M | $318.52M | $332.83M | $328.28M | $317.11M | $311.21M | $320.42M | $321.59M | $325.76M | $323.15M | $346.16M | $338.04M | $352.99M | $360.46M | $383.87M | $388.76M |
| QoQ Change | — | +6.9% | +2.7% | +7.6% | +4.1% | +7.3% | +4.5% | -1.4% | -3.4% | -1.9% | +3.0% | +0.4% | +1.3% | -0.8% | +7.1% | -2.3% | +4.4% | +2.1% | +6.5% | +1.3% |
| YoY Change | — | — | — | — | +23.0% | +23.4% | +25.6% | +15.1% | +6.8% | -2.3% | -3.7% | -2.0% | +2.7% | +3.8% | +8.0% | +5.1% | +8.4% | +11.5% | +10.9% | +15.0% |
| Segment | Q3 '26 |
|---|---|
| Semiconductor Process Control | $344.30M |
| PCB And Component Inspection | $29.91M |
| Specialty Semiconductor Process | $13.81M |
| Total | $388.76M |